{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T11:37:53Z","timestamp":1772537873971,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Collaborative Innovation Center of Chinese Ministry of Education","award":["2020-39"],"award-info":[{"award-number":["2020-39"]}]},{"name":"the Guizhou provincial \"hundred\" level innovative talents funds","award":["GCC-2022-038-1"],"award-info":[{"award-number":["GCC-2022-038-1"]}]},{"name":"the Zunyi city science and technology bureau support foundation","award":["ZSKHZ-2022-267"],"award-info":[{"award-number":["ZSKHZ-2022-267"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12035-025-05044-8","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T07:44:05Z","timestamp":1747899845000},"page":"12394-12412","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Deletion of ZNRF2 Exacerbates MPTP-Induced Parkinson\u2019s Disease by Activating mTOR-Mediated Neuroinflammatory Pathways"],"prefix":"10.1007","volume":"62","author":[{"given":"Fanshi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuling","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zucai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"5044_CR1","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/s1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio A, Schwarzschild MA (2016) The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol 15:1257\u20131272. https:\/\/doi.org\/10.1016\/s1474-4422(16)30230-7","journal-title":"Lancet Neurol"},{"key":"5044_CR2","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/j.cell.2022.04.013","volume":"185","author":"S Battaglioni","year":"2022","unstructured":"Battaglioni S et al (2022) mTOR substrate phosphorylation in growth control. Cell 185:1814\u20131836. https:\/\/doi.org\/10.1016\/j.cell.2022.04.013","journal-title":"Cell"},{"key":"5044_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrd3321","volume":"10","author":"L Bedford","year":"2011","unstructured":"Bedford L et al (2011) Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nat Rev Drug Discov 10:29\u201346. https:\/\/doi.org\/10.1038\/nrd3321","journal-title":"Nat Rev Drug Discov"},{"key":"5044_CR4","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1007\/s12035-022-02851-1","volume":"59","author":"T Behl","year":"2022","unstructured":"Behl T et al (2022) Exploring the role of ubiquitin-proteasome system in Parkinson\u2019s disease. Mol Neurobiol 59:4257\u20134273. https:\/\/doi.org\/10.1007\/s12035-022-02851-1","journal-title":"Mol Neurobiol"},{"issue":"Suppl 1","key":"5044_CR5","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/j.expneurol.2004.08.021","volume":"191","author":"R Betarbet","year":"2005","unstructured":"Betarbet R et al (2005) Ubiquitin-proteasome system and Parkinson\u2019s diseases. Exp Neurol 191(Suppl 1):S17-27. https:\/\/doi.org\/10.1016\/j.expneurol.2004.08.021","journal-title":"Exp Neurol"},{"key":"5044_CR6","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.7150\/thno.83082","volume":"13","author":"X Bo","year":"2023","unstructured":"Bo X et al (2023) Deletion of Calhm2 alleviates MPTP-induced Parkinson\u2019s disease pathology by inhibiting EFHD2-STAT3 signaling in microglia. Theranostics 13:1809\u20131822. https:\/\/doi.org\/10.7150\/thno.83082","journal-title":"Theranostics"},{"key":"5044_CR7","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.cmet.2017.11.006","volume":"27","author":"M Brandt","year":"2018","unstructured":"Brandt M et al (2018) mTORC1 inactivation promotes colitis-induced colorectal cancer but protects from APC loss-dependent tumorigenesis. Cell Metab 27:118-135.e8. https:\/\/doi.org\/10.1016\/j.cmet.2017.11.006","journal-title":"Cell Metab"},{"key":"5044_CR8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12974-021-02349-y","volume":"18","author":"J Chen","year":"2021","unstructured":"Chen J et al (2021) p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson\u2019s disease. J Neuroinflammation 18:295. https:\/\/doi.org\/10.1186\/s12974-021-02349-y","journal-title":"J Neuroinflammation"},{"key":"5044_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejphar.2015.09.029","volume":"768","author":"Y Chen","year":"2015","unstructured":"Chen Y et al (2015) Neuroprotective effects of geniposide in the MPTP mouse model of Parkinson\u2019s disease. European Journal of Pharmacology 768:21\u201327. https:\/\/doi.org\/10.1016\/j.ejphar.2015.09.029","journal-title":"European Journal of Pharmacology"},{"key":"5044_CR10","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/s41467-020-15119-w","volume":"11","author":"I Choi","year":"2020","unstructured":"Choi I et al (2020) Microglia clear neuron-released \u03b1-synuclein via selective autophagy and prevent neurodegeneration. Nat Commun 11:1386. https:\/\/doi.org\/10.1038\/s41467-020-15119-w","journal-title":"Nat Commun"},{"key":"5044_CR11","doi-asserted-by":"publisher","first-page":"e3083","DOI":"10.1002\/jgm.3083","volume":"21","author":"Z Cui","year":"2019","unstructured":"Cui Z et al (2019) Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153\u20133p\/ZNRF2 axis. J Gene Med 21:e3083. https:\/\/doi.org\/10.1002\/jgm.3083","journal-title":"J Gene Med"},{"key":"5044_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/glia.22350","volume":"61","author":"C Cunningham","year":"2013","unstructured":"Cunningham C (2013) Microglia and neurodegeneration: the role of systemic inflammation. Glia 61:71\u201390. https:\/\/doi.org\/10.1002\/glia.22350","journal-title":"Glia"},{"key":"5044_CR13","doi-asserted-by":"publisher","first-page":"110491","DOI":"10.1016\/j.cbi.2023.110491","volume":"379","author":"MA Desouky","year":"2023","unstructured":"Desouky MA et al (2023) Roflumilast escalates \u03b1-synuclein aggregate degradation in rotenone-induced Parkinson\u2019s disease in rats: modulation of the ubiquitin-proteasome system and endoplasmic reticulum stress. Chem Biol Interact 379:110491. https:\/\/doi.org\/10.1016\/j.cbi.2023.110491","journal-title":"Chem Biol Interact"},{"key":"5044_CR14","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1074\/mcp.M800544-MCP200","volume":"8","author":"F Dubois","year":"2009","unstructured":"Dubois F et al (2009) Differential 14\u20133\u20133 affinity capture reveals new downstream targets of phosphatidylinositol 3-kinase signaling. Mol Cell Proteomics 8:2487\u201399. https:\/\/doi.org\/10.1074\/mcp.M800544-MCP200","journal-title":"Mol Cell Proteomics"},{"key":"5044_CR15","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao C et al (2023) Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther 8:359. https:\/\/doi.org\/10.1038\/s41392-023-01588-0","journal-title":"Signal Transduct Target Ther"},{"key":"5044_CR16","doi-asserted-by":"publisher","unstructured":"Gordon, R., et al. 2018. Inflammasome inhibition prevents \u03b1-synuclein pathology and dopaminergic neurodegeneration in mice. Sci Transl Med, 10. https:\/\/doi.org\/10.1126\/scitranslmed.aah4066","DOI":"10.1126\/scitranslmed.aah4066"},{"key":"5044_CR17","doi-asserted-by":"publisher","first-page":"113759","DOI":"10.1016\/j.expneurol.2021.113759","volume":"342","author":"C Gu","year":"2021","unstructured":"Gu C et al (2021) ZNRF2 attenuates focal cerebral ischemia\/reperfusion injury in rats by inhibiting mTORC1-mediated autophagy. Exp Neurol 342:113759. https:\/\/doi.org\/10.1016\/j.expneurol.2021.113759","journal-title":"Exp Neurol"},{"key":"5044_CR18","doi-asserted-by":"publisher","unstructured":"Han, R., et al. 2024. Deficiency of parkin causes neurodegeneration and accumulation of pathological \u03b1-synuclein in monkey models. J Clin Invest, 134. https:\/\/doi.org\/10.1172\/jci179633","DOI":"10.1172\/jci179633"},{"key":"5044_CR19","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1080\/15548627.2019.1596481","volume":"15","author":"X Han","year":"2019","unstructured":"Han X et al (2019) Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease. Autophagy 15:1860\u20131881. https:\/\/doi.org\/10.1080\/15548627.2019.1596481","journal-title":"Autophagy"},{"key":"5044_CR20","doi-asserted-by":"publisher","unstructured":"Hoxhaj, G., et al. 2016. The E3 ubiquitin ligase ZNRF2 is a substrate of mTORC1 and regulates its activation by amino acids. Elife, 5. https:\/\/doi.org\/10.7554\/eLife.12278","DOI":"10.7554\/eLife.12278"},{"key":"5044_CR21","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/glia.23760","volume":"68","author":"Y Hu","year":"2020","unstructured":"Hu Y et al (2020) mTOR-mediated metabolic reprogramming shapes distinct microglia functions in response to lipopolysaccharide and ATP. Glia 68:1031\u20131045. https:\/\/doi.org\/10.1002\/glia.23760","journal-title":"Glia"},{"key":"5044_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13045-019-0754-1","volume":"12","author":"H Hua","year":"2019","unstructured":"Hua H et al (2019) Targeting mTOR for cancer therapy. J Hematol Oncol 12:71. https:\/\/doi.org\/10.1186\/s13045-019-0754-1","journal-title":"J Hematol Oncol"},{"key":"5044_CR23","doi-asserted-by":"publisher","unstructured":"Kawahata, I. & Fukunaga, K. 2020. Degradation of tyrosine hydroxylase by the ubiquitin-proteasome system in the pathogenesis of Parkinson\u2019s disease and dopa-responsive dystonia. Int J Mol Sci 21. https:\/\/doi.org\/10.3390\/ijms21113779","DOI":"10.3390\/ijms21113779"},{"key":"5044_CR24","doi-asserted-by":"publisher","first-page":"eadd0499","DOI":"10.1126\/scitranslmed.add0499","volume":"15","author":"MR Khan","year":"2023","unstructured":"Khan MR et al (2023) Enhanced mTORC1 signaling and protein synthesis in pathologic \u03b1-synuclein cellular and animal models of Parkinson\u2019s disease. Sci Transl Med 15:eadd0499. https:\/\/doi.org\/10.1126\/scitranslmed.add0499","journal-title":"Sci Transl Med"},{"key":"5044_CR25","doi-asserted-by":"publisher","first-page":"101816","DOI":"10.1016\/j.arr.2022.101816","volume":"84","author":"A Kulkarni","year":"2023","unstructured":"Kulkarni A et al (2023) Proteostasis in Parkinson\u2019s disease: recent development and possible implication in diagnosis and therapeutics. Ageing Res Rev 84:101816. https:\/\/doi.org\/10.1016\/j.arr.2022.101816","journal-title":"Ageing Res Rev"},{"key":"5044_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41418-018-0124-5","volume":"26","author":"E Lee","year":"2019","unstructured":"Lee E et al (2019) MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration. Cell Death Differ 26:213\u2013228. https:\/\/doi.org\/10.1038\/s41418-018-0124-5","journal-title":"Cell Death Differ"},{"key":"5044_CR27","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12974-023-02956-x","volume":"20","author":"T Li","year":"2023","unstructured":"Li T et al (2023) The role of Nurr1-miR-30e-5p-NLRP3 axis in inflammation-mediated neurodegeneration: insights from mouse models and patients\u2019 studies in Parkinson\u2019s disease. J Neuroinflammation 20:274. https:\/\/doi.org\/10.1186\/s12974-023-02956-x","journal-title":"J Neuroinflammation"},{"key":"5044_CR28","doi-asserted-by":"publisher","unstructured":"Machado, V., et al. 2016. Microglia-mediated neuroinflammation and neurotrophic factor-induced protection in the MPTP mouse model of Parkinson\u2019s disease-lessons from transgenic mice. Int J Mol Sci 17. https:\/\/doi.org\/10.3390\/ijms17020151","DOI":"10.3390\/ijms17020151"},{"key":"5044_CR29","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12943-023-01820-z","volume":"22","author":"A Marques-Ramos","year":"2023","unstructured":"Marques-Ramos A, Cervantes R (2023) Expression of mTOR in normal and pathological conditions. Mol Cancer 22:112. https:\/\/doi.org\/10.1186\/s12943-023-01820-z","journal-title":"Mol Cancer"},{"key":"5044_CR30","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1002\/mds.21013","volume":"21","author":"CW Olanow","year":"2006","unstructured":"Olanow CW, Mcnaught KS (2006) Ubiquitin-proteasome system and Parkinson\u2019s disease. Mov Disord 21:1806\u201323. https:\/\/doi.org\/10.1002\/mds.21013","journal-title":"Mov Disord"},{"key":"5044_CR31","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","volume":"8","author":"V Panwar","year":"2023","unstructured":"Panwar V et al (2023) Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease. Signal Transduct Target Ther 8:375. https:\/\/doi.org\/10.1038\/s41392-023-01608-z","journal-title":"Signal Transduct Target Ther"},{"key":"5044_CR32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0165-0270(80)90021-7","volume":"3","author":"G Paxinos","year":"1980","unstructured":"Paxinos G et al (1980) AChE-stained horizontal sections of the rat brain in stereotaxic coordinates. J Neurosci Methods 3:129\u201349. https:\/\/doi.org\/10.1016\/0165-0270(80)90021-7","journal-title":"J Neurosci Methods"},{"key":"5044_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12943-023-01825-8","volume":"22","author":"J Pencik","year":"2023","unstructured":"Pencik J et al (2023) STAT3\/LKB1 controls metastatic prostate cancer by regulating mTORC1\/CREB pathway. Mol Cancer 22:133. https:\/\/doi.org\/10.1186\/s12943-023-01825-8","journal-title":"Mol Cancer"},{"key":"5044_CR34","doi-asserted-by":"publisher","first-page":"eadh3347","DOI":"10.1126\/sciadv.adh3347","volume":"9","author":"W Peng","year":"2023","unstructured":"Peng W et al (2023) Parkin regulates amino acid homeostasis at mitochondria-lysosome (M\/L) contact sites in Parkinson\u2019s disease. Sci Adv 9:eadh3347. https:\/\/doi.org\/10.1126\/sciadv.adh3347","journal-title":"Sci Adv"},{"key":"5044_CR35","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/jcb.20587","volume":"97","author":"V Plans","year":"2006","unstructured":"Plans V et al (2006) The RING finger protein RNF8 recruits UBC13 for lysine 63-based self polyubiquitylation. J Cell Biochem 97:572\u201382. https:\/\/doi.org\/10.1002\/jcb.20587","journal-title":"J Cell Biochem"},{"key":"5044_CR36","doi-asserted-by":"publisher","first-page":"101907","DOI":"10.1016\/j.arr.2023.101907","volume":"87","author":"E Possemato","year":"2023","unstructured":"Possemato E et al (2023) The role of dopamine in NLRP3 inflammasome inhibition: implications for neurodegenerative diseases. Ageing Res Rev 87:101907. https:\/\/doi.org\/10.1016\/j.arr.2023.101907","journal-title":"Ageing Res Rev"},{"key":"5044_CR37","doi-asserted-by":"publisher","first-page":"e1364","DOI":"10.1038\/cddis.2014.333","volume":"5","author":"J Roman\u00ed-Aumedes","year":"2014","unstructured":"Roman\u00ed-Aumedes J et al (2014) Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson\u2019s disease. Cell Death Dis 5:e1364. https:\/\/doi.org\/10.1038\/cddis.2014.333","journal-title":"Cell Death Dis"},{"key":"5044_CR38","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12974-021-02158-3","volume":"18","author":"J Rostami","year":"2021","unstructured":"Rostami J et al (2021) Crosstalk between astrocytes and microglia results in increased degradation of \u03b1-synuclein and amyloid-\u03b2 aggregates. J Neuroinflammation 18:124. https:\/\/doi.org\/10.1186\/s12974-021-02158-3","journal-title":"J Neuroinflammation"},{"key":"5044_CR39","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/mds.27602","volume":"34","author":"K Seppi","year":"2019","unstructured":"Seppi K et al (2019) Update on treatments for nonmotor symptoms of Parkinson\u2019s disease-an evidence-based medicine review. Mov Disord 34:180\u2013198. https:\/\/doi.org\/10.1002\/mds.27602","journal-title":"Mov Disord"},{"key":"5044_CR40","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1111\/jcmm.17900","volume":"27","author":"F Shi","year":"2023","unstructured":"Shi F et al (2023) A pancancer analysis of the oncogenic role of ZNRF2 in human tumours. J Cell Mol Med 27:3296\u20133312. https:\/\/doi.org\/10.1111\/jcmm.17900","journal-title":"J Cell Mol Med"},{"key":"5044_CR41","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.pharmthera.2007.04.001","volume":"114","author":"F Sun","year":"2007","unstructured":"Sun F et al (2007) Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson\u2019s disease. Pharmacol Ther 114:327\u201344. https:\/\/doi.org\/10.1016\/j.pharmthera.2007.04.001","journal-title":"Pharmacol Ther"},{"key":"5044_CR42","doi-asserted-by":"publisher","first-page":"168144","DOI":"10.1016\/j.jmb.2023.168144","volume":"435","author":"C Themistokleous","year":"2023","unstructured":"Themistokleous C et al (2023) Role of autophagy pathway in Parkinson\u2019s disease and related genetic neurological disorders. J Mol Biol 435:168144. https:\/\/doi.org\/10.1016\/j.jmb.2023.168144","journal-title":"J Mol Biol"},{"key":"5044_CR43","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/s1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E et al (2021) Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol 20:385\u2013397. https:\/\/doi.org\/10.1016\/s1474-4422(21)00030-2","journal-title":"Lancet Neurol"},{"key":"5044_CR44","doi-asserted-by":"publisher","unstructured":"Torii, S., et al. 2020. Mitochondrial E3 ubiquitin ligase parkin: relationships with other causal proteins in familial Parkinson\u2019s disease and its substrate-involved mouse experimental models. Int J Mol Sci, 21. https:\/\/doi.org\/10.3390\/ijms21041202","DOI":"10.3390\/ijms21041202"},{"key":"5044_CR45","doi-asserted-by":"publisher","first-page":"e1143575","DOI":"10.1080\/19420889.2016.1143575","volume":"9","author":"S Wakatsuki","year":"2016","unstructured":"Wakatsuki S, Araki T (2016) NADPH oxidases promote apoptosis by activating ZNRF1 ubiquitin ligase in neurons treated with an exogenously applied oxidant. Commun Integr Biol 9:e1143575. https:\/\/doi.org\/10.1080\/19420889.2016.1143575","journal-title":"Commun Integr Biol"},{"key":"5044_CR46","doi-asserted-by":"publisher","first-page":"746","DOI":"10.4103\/1673-5374.354509","volume":"18","author":"S Wakatsuki","year":"2023","unstructured":"Wakatsuki S, Araki T (2023) Novel insights into the mechanism of reactive oxygen species-mediated neurodegeneration. Neural Regen Res 18:746\u2013749. https:\/\/doi.org\/10.4103\/1673-5374.354509","journal-title":"Neural Regen Res"},{"key":"5044_CR47","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ejphar.2016.08.011","volume":"791","author":"L Xiao-Feng","year":"2016","unstructured":"Xiao-Feng L et al (2016) Protective role of 6-hydroxy-1-H-indazole in an MPTP-induced mouse model of Parkinson\u2019s disease. Eur J Pharmacol 791:348\u2013354. https:\/\/doi.org\/10.1016\/j.ejphar.2016.08.011","journal-title":"Eur J Pharmacol"},{"key":"5044_CR48","doi-asserted-by":"publisher","first-page":"34678","DOI":"10.18632\/oncotarget.16149","volume":"8","author":"Q Xiao","year":"2017","unstructured":"Xiao Q et al (2017) MicroRNA-100 suppresses human osteosarcoma cell proliferation and chemo-resistance via ZNRF2. Oncotarget 8:34678\u201334686. https:\/\/doi.org\/10.18632\/oncotarget.16149","journal-title":"Oncotarget"},{"key":"5044_CR49","doi-asserted-by":"publisher","first-page":"102032","DOI":"10.1016\/j.arr.2023.102032","volume":"90","author":"H Yu","year":"2023","unstructured":"Yu H et al (2023) Metabolic reprogramming and polarization of microglia in Parkinson\u2019s disease: role of inflammasome and iron. Ageing Res Rev 90:102032. https:\/\/doi.org\/10.1016\/j.arr.2023.102032","journal-title":"Ageing Res Rev"},{"key":"5044_CR50","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","volume":"24","author":"SP Yun","year":"2018","unstructured":"Yun SP et al (2018) Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson\u2019s disease. Nat Med 24:931\u2013938. https:\/\/doi.org\/10.1038\/s41591-018-0051-5","journal-title":"Nat Med"},{"key":"5044_CR51","doi-asserted-by":"publisher","first-page":"110330","DOI":"10.1016\/j.cellsig.2022.110330","volume":"94","author":"R Zhang","year":"2022","unstructured":"Zhang R et al (2022) NOX2-derived hydrogen peroxide impedes the AMPK\/Akt-mTOR signaling pathway contributing to cell death in neuronal cells. Cell Signal 94:110330. https:\/\/doi.org\/10.1016\/j.cellsig.2022.110330","journal-title":"Cell Signal"},{"key":"5044_CR52","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W et al (2023) Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther 8:267. https:\/\/doi.org\/10.1038\/s41392-023-01486-5","journal-title":"Signal Transduct Target Ther"},{"key":"5044_CR53","first-page":"4011","volume":"20","author":"XF Zhang","year":"2016","unstructured":"Zhang XF et al (2016) The role of ZNRF2 in the growth of non-small cell lung cancer. Eur Rev Med Pharmacol Sci 20:4011\u20134017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"5044_CR54","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.bbr.2015.07.021","volume":"293","author":"Y Zhang","year":"2015","unstructured":"Zhang Y et al (2015) Neuroprotective effects of (Val8)GLP-1-Glu-PAL in the MPTP Parkinson\u2019s disease mouse model. Behavioural Brain Res 293:107\u2013113. https:\/\/doi.org\/10.1016\/j.bbr.2015.07.021","journal-title":"Behavioural Brain Res"},{"key":"5044_CR55","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.chembiol.2017.03.005","volume":"24","author":"Y Zhang","year":"2017","unstructured":"Zhang Y et al (2017) Rescue of Pink1 deficiency by stress-dependent activation of autophagy. Cell Chem Biol 24:471-480.e4. https:\/\/doi.org\/10.1016\/j.chembiol.2017.03.005","journal-title":"Cell Chem Biol"},{"key":"5044_CR56","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1161\/circulationaha.114.011079","volume":"131","author":"QD Zhao","year":"2015","unstructured":"Zhao QD et al (2015) NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt\/mTOR and NF\u03baB signaling pathways. Circulation 131:643\u201355. https:\/\/doi.org\/10.1161\/circulationaha.114.011079","journal-title":"Circulation"},{"key":"5044_CR57","doi-asserted-by":"publisher","unstructured":"Zhu, Z., et al. 2019. Balancing mTOR signaling and autophagy in the treatment of Parkinson\u2019s disease. Int J Mol Sci, 20. https:\/\/doi.org\/10.3390\/ijms20030728","DOI":"10.3390\/ijms20030728"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05044-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05044-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05044-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T18:02:36Z","timestamp":1757786556000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05044-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":57,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["5044"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05044-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"21 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments comply with the ARRIVE guidelines. This study was approved by the Ethics Committee of the Affiliated Hospital of Zunyi Medical University (ethics no.: zyfy-an-2023\u20130311).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}